Department of Health Disparities Research, The University of Texas MD Anderson Cancer Center, Houston, TX 77030-4009, USA.
Ethn Dis. 2012 Autumn;22(4):479-85.
Our study aimed to assess patient's perceptions of generic drugs and utilization of generic drug discount programs.
DESIGN, SETTING AND PARTICIPANTS: A survey was administered to adult participants at community health centers and community-based organizations in Houston, Texas, USA (n=525).
Multivariate logistic regression was used to quantify the strength of association between generic drug perception and utilization of generic drug discount programs.
Respondents who agreed that "Generic prescription drugs are as effective as brand name prescription drugs," were 3 times as likely to utilize generic drug discount programs (AOR: 3.0, 95% CI: 1.8-4.8, P<.001). Compared to non-Hispanic Whites, African Americans (OR: 10.2; 95% CI: 1.4-76.4) and Hispanics (OR: 10.3; 95% CI: 1.3-79.4) were 10 times as likely to agree that generic drugs have more side effects than brand name drugs.
Race/ethnicity had no impact in utilization of generic drug discount programs, despite racial disparities in perception toward generic drugs' side effects and generic drugs being inferior to brand name drugs.
我们的研究旨在评估患者对仿制药的看法以及对仿制药折扣计划的利用情况。
设计、地点和参与者:对美国得克萨斯州休斯顿的社区卫生中心和社区组织的成年参与者进行了一项调查(n=525)。
多变量逻辑回归用于量化仿制药认知与仿制药折扣计划利用之间的关联强度。
同意“仿制药与品牌药一样有效”的受访者使用仿制药折扣计划的可能性是不同意者的 3 倍(优势比:3.0,95%置信区间:1.8-4.8,P<.001)。与非西班牙裔白人相比,非裔美国人(比值比:10.2;95%置信区间:1.4-76.4)和西班牙裔(比值比:10.3;95%置信区间:1.3-79.4)更有可能认为仿制药比品牌药副作用更多。
尽管在对仿制药副作用和仿制药劣于品牌药的看法上存在种族差异,但种族/民族对仿制药折扣计划的利用没有影响。